MBB (MBB) investor relations material

Executive summary

• H1 2026 revenue was €536 million, down 1.7% year-on-year, but adjusted EBITDA surged 53.4% to €117.1 million, with margin rising to 21.8% from 14.1% in the prior year.

• Q2 2026 revenue rose 5% year-on-year to nearly €300 million, with adjusted EBITDA up 62% to €75 million and margin at 25.1%.

• Portfolio focus sharpened by the sale of CT Formpolster to Nexeras, freeing capacity for M&A and expected to have a moderate positive impact on net cash.

• Management increased full-year 2026 EBITDA guidance to €180–200 million, with revenue expected at €730–780 million.

• The group maintained a strong financial position, with an equity ratio of up to 68% and net cash of up to €769 million as of June 30, 2026.

Financial highlights

• Adjusted EBIT increased 69.4% year-on-year to €88.3 million.

• Cost of materials fell 15.5% to €235.7 million, while personnel expenses rose 5.7% to €164.9 million due to headcount growth.

• Liquid funds (including securities and gold) totaled €830.2 million, up from €821.4 million at year-end 2025.

• Dividend of €1.21 per share for FY2025 was paid in June 2026.

• Share buybacks and dividends to return about €30 million to shareholders in 2026.

Outlook and guidance

• Full-year 2026 EBITDA guidance raised to €180–200 million (from €160–180 million); revenue guidance at €730–780 million.

• Adjusted group EBITDA margin guidance for 2026 increased to 18–20% (from 15–18%), with revenue expected at €1.1–1.2 billion.

• Delignit raised 2026 revenue guidance to €68 million, maintaining a 7–8% EBITDA margin.

• Aumann expects 2026 revenue of €160 million and a 6–8% EBITDA margin.

• Vorwerk confirmed or increased 2026 outlook, citing strong order backlogs and demand.